Physician

Aziz Khan, M.D.

According to 2025 Medicare claims, Aziz Khan, M.D. (NPI: 1699702316) practices hematology/oncology in the Springfield, IL market, with the plurality of this provider's patient population coming from Sangamon, IL. This provider's primary affiliated billing organization is SIU PHYSICIANS & SURGEONS, INC (NPI: 1558385989; TIN: 36-4143823) and primary practice location at 62702-4901. Khan is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 385 traditional Medicare patients, billed 58,487 HCPCS/CPT codes, and received $777,980 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 652 prescription claims across 129 beneficiaries totaling $3,514,224 in drug costs, led by Xtandi (Enzalutamide). 2022 DME data shows 97 claims. Open Payments data shows 1 records totaling $98. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $573,853 to $3,514,224. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	287	78,818	$562,977
2016	318	107,843	$775,502
2017	358	79,745	$841,244
2018	408	102,677	$1,046,044
2019	449	89,777	$1,095,388
2020	582	121,066	$2,090,073
2021	586	154,424	$2,141,376
2022	489	81,011	$1,364,001
2023	373	46,343	$728,810
2024	385	58,487	$777,980

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	72	368	$573,853
2016	68	454	$639,467
2017	86	529	$889,871
2018	114	756	$1,730,406
2019	113	879	$2,513,401
2020	154	1,013	$2,197,286
2021	150	878	$2,388,890
2022	133	686	$3,149,007
2023	130	703	$3,576,128
2024	129	652	$3,514,224

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	100	$9,704
2016	N/R	43	$2,717
2017	N/R	107	$19,242
2018	N/R	103	$10,619
2019	N/R	93	$5,811
2020	N/R	104	$3,525
2021	N/R	100	$4,541
2022	N/R	97	$2,451
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	39	170	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	293	513	$91
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	34	40	$41
96523	Irrigation of implanted venous access drug delivery device	28	65	$17
96372	Injection of drug or substance under skin or into muscle	36	88	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	27	1,230	$581,490
Imbruvica	Ibrutinib	25	700	$407,684
Doptelet	Avatrombopag Maleate	15	780	$352,663
Lenvima	Lenvatinib Mesylate	12	360	$296,878
Brukinsa	Zanubrutinib	12	420	$210,800

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$98	Incyte Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aziz Khan, M.D.?

Tedicare shows public-source Medicare data for Aziz Khan, M.D. (NPI 1699702316), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aziz Khan, M.D. have ACO affiliation data?

Aziz Khan, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Aziz Khan, M.D.?

Aziz Khan, M.D. is linked to SIU PHYSICIANS & SURGEONS, INC (billing NPI 1558385989) in the available physician profile data.

Does Aziz Khan, M.D. have Open Payments data?

Aziz Khan, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.